The Kable

The Kable

Share this post

The Kable
The Kable
💊 Amazon’s virtual clinic takes off; Boomtime for biosimilars; GSK’s new TB treatment
Copy link
Facebook
Email
Notes
More

💊 Amazon’s virtual clinic takes off; Boomtime for biosimilars; GSK’s new TB treatment

#217 | Care for some bone marrow in a dish?

Vinod's avatar
Vinod
Nov 16, 2022
∙ Paid

Share this post

The Kable
The Kable
💊 Amazon’s virtual clinic takes off; Boomtime for biosimilars; GSK’s new TB treatment
Copy link
Facebook
Email
Notes
More
Share

Hello and welcome back to The Kable. It has been a relatively slow news week thus far, and it feels like everybody is just waiting for something. Like Immunogen, who has been waiting 41 years for a solo drug approval, finally scored a nod from the US FDA for its ovarian cancer drug this week.

Amazon's push into healthcare continues to gather steam. In its latest offering, the e-commerce major has launched a virtual clinic for more than 20 common health conditions.

In the UK, people nostalgic for the days of WWII are rejoicing after supermarkets started rationing eggs being sold to customers. Thank you, bird flu.

And finally, many days after announcing a truce, aid is at last making its way to Ethiopia's Tigray region.

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More